Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sanofi Ready To Roll Out Teizeild After EU Okay
Jan 12 2026
•
By
Kevin Grogan
Teizeild is the first disease-modifying therapy for type 1 diabetes approved in the EU • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip